Sirona Biochem Corp is a development-stage biotechnology company headquartered in Vancouver, Canada, specializing in the discovery and development of cosmetic ingredients and pharmaceutical active compounds. The company operates a technology platform centered on carbohydrate molecule stabilization, developed at its laboratory facility in France. Sirona Biochem focuses on three primary areas: therapeutics for conditions including diabetes, inflammation, and infection; cosmeceuticals featuring anti-aging and skin-lightening agents; and biological ingredients that serve as inducers and adjuvants for biological development and preservation. The company maintains six distinct product lines addressing these sectors, with compounds developed through advanced chemical techniques including glycomimetic technology utilizing fluorine atom properties. Sirona Biochem licenses its developed active ingredients to partner organizations, positioning itself as an innovator in the biochemical ingredient space for both pharmaceutical and cosmetic applications.